FindTrial
Sign In

Comparison of nalbuphine with both levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under spinal anaesthesia

Comparison of nalbuphine as an adjuvant to levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under subarachnoid block : a prospective randomised comparative study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049589
Enrollment
60
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: subarachnoid block: nalbuphine as an adjuvant to levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% Intervention2: subarachnoid block: nalbuphine as an adjuvant to levobupivacain

Sponsors

Mahatma Gandhi medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient scheduled for elective surgery under subarachnoid block 2. patient of either gender aged 18-60 years 3. patient under ASA I / II/ III 4. patients with written and informed consent

Exclusion criteria

Exclusion criteria: 1. patient under ASA GRADE III / IV / and V 2. patient allergic to study drugs. 3. non consenting patient.

Design outcomes

Primary

MeasureTime frame
The duration of spinal analgesia following intrathecal nalbuphine as an adjuvant to levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under subarachnoid blockTimepoint: Baseline,1-min,20min,30min,60min,90min,120min,180min.—

Secondary

MeasureTime frame
peak level of sensory blockTimepoint: upto 15 minutes after spinal anaesthesia—

Countries

India

Contacts

Public ContactSanam Fatma

mahatma gandhi medical college and hospital

drpriyamvada@hotmail.co.uk7976568252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026